1
|
Liu XY, Wang YM, Zhang XY, Jia MQ, Duan HQ, Qin N, Chen Y, Yu Y, Duan XC. Alkaloid Derivative ( Z)-3β-Ethylamino-Pregn-17(20)-en Inhibits Triple-Negative Breast Cancer Metastasis and Angiogenesis by Targeting HSP90α. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27207132. [PMID: 36296726 PMCID: PMC9611734 DOI: 10.3390/molecules27207132] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/26/2022] [Revised: 10/17/2022] [Accepted: 10/19/2022] [Indexed: 11/25/2022]
Abstract
Metastasis is an important cause of cancer-related death. Previous studies in our laboratory found that pregnane alkaloids from Pachysandra terminalis had antimetastatic activity against breast cancer cells. In the current study, we demonstrated that treatment with one of the alkaloid derivatives, (Z)-3β-ethylamino-pregn-17(20)-en (1), led to the downregulation of the HIF-1α/VEGF/VEGFR2 pathway, suppressed the phosphorylation of downstream molecules Akt, mTOR, FAK, and inhibited breast cancer metastasis and angiogenesis both in vitro and in vivo. Furthermore, the antimetastasis and antiangiogenesis effects of 1 treatment (40 mg/kg) were more effective than that of Sorafenib (50 mg/kg). Surface plasmon resonance (SPR) analysis was performed and the result suggested that HSP90α was a direct target of 1. Taken together, our results suggested that compound 1 might represent a candidate antitumor agent for metastatic breast cancer.
Collapse
Affiliation(s)
- Xin-Yao Liu
- School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
| | - Yu-Miao Wang
- School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
| | - Xiang-Yu Zhang
- School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
| | - Mei-Qi Jia
- School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
| | - Hong-Quan Duan
- School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
- Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
- Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin 300070, China
| | - Nan Qin
- School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
| | - Ying Chen
- School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
| | - Yang Yu
- School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
- Correspondence: (Y.Y.); (X.-C.D.); Tel.: +86-22-83336680 (X.-C.D.); Fax: +86-22-83336560 (X.-C.D.)
| | - Xiao-Chuan Duan
- School of Pharmacy, Tianjin Medical University, Tianjin 300070, China
- School of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin 300070, China
- Correspondence: (Y.Y.); (X.-C.D.); Tel.: +86-22-83336680 (X.-C.D.); Fax: +86-22-83336560 (X.-C.D.)
| |
Collapse
|
2
|
Huang Y, Li G, Hong C, Zheng X, Yu H, Zhang Y. Potential of Steroidal Alkaloids in Cancer: Perspective Insight Into Structure-Activity Relationships. Front Oncol 2021; 11:733369. [PMID: 34616681 PMCID: PMC8489381 DOI: 10.3389/fonc.2021.733369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Accepted: 08/12/2021] [Indexed: 11/13/2022] Open
Abstract
Steroidal alkaloids contain both steroidal and alkaloid properties in terms of chemical properties and pharmacological activities. Due to outstanding biological activities such as alkaloids and similar pharmacological effects to other steroids, steroidal alkaloids have received special attention in anticancer activity recently. Substituted groups in chemical structure play markedly important roles in biological activities. Therefore, the effective way to obtain lead compounds quickly is structural modification, which is guided by structure-activity relationships (SARs). This review presents the SAR of steroidal alkaloids and anticancer, including pregnane alkaloids, cyclopregnane alkaloids, cholestane alkaloids, C-nor-D-homosteroidal alkaloids, and bis-steroidal pyrazine. A summary of SAR can powerfully help to design and synthesize more lead compounds.
Collapse
Affiliation(s)
- Ying Huang
- Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China
| | - Gen Li
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Chong Hong
- Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China
| | - Xia Zheng
- The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China
| | - Haiyang Yu
- State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China
| | - Yan Zhang
- Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China
| |
Collapse
|
3
|
Qiu J, Chen W, Jiang Y, Chen J, Zhang Y, Gu X. Assessment of a bifendate derivative bearing a 6,7-dihydro-dibenzo[ c, e]azepine scaffold as a potential anti-metastatic agent. MEDCHEMCOMM 2018; 9:1826-1830. [PMID: 30542532 DOI: 10.1039/c8md00294k] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/11/2018] [Accepted: 09/17/2018] [Indexed: 11/21/2022]
Abstract
Multidrug resistance (MDR) and metastasis are major causes of mortality in patients with cancer. We recently reported a bifendate derivative bearing a dibenzo[c,e]azepine scaffold (4i) as a P-gp and BCRP-medicated MDR reversal agent. As a continuation of the previous research, its ability to inhibit cancer metastasis was investigated in MDA-MB-231 cells in the present work. Wound-healing and chamber migration assays showed that 4i could significantly attenuate the migration of MDA-MB-231 cells. Additionally, 4i obviously suppressed the invasive activity of MDA-MB-231 cells, thus displaying potential anti-metastasis activity. Preliminary mechanism studies indicated that the anti-metastasis activity of 4i was associated with the inhibitory effect on the activity and expression of MMP-2 and MMP-9. These results, together with the previous findings, suggest that compound 4i could be a promising lead for the development of novel anti-cancer agents with anti-MDR and metastatic activities.
Collapse
Affiliation(s)
- Jingying Qiu
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy , Xuzhou Medical University , Xuzhou 221004 , People's Republic of China . ; ; Tel: +86 516 83262137
| | - Wang Chen
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy , Xuzhou Medical University , Xuzhou 221004 , People's Republic of China . ; ; Tel: +86 516 83262137
| | - Yanfei Jiang
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy , Xuzhou Medical University , Xuzhou 221004 , People's Republic of China . ; ; Tel: +86 516 83262137
| | - Jing Chen
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy , Xuzhou Medical University , Xuzhou 221004 , People's Republic of China . ; ; Tel: +86 516 83262137
| | - Yinpeng Zhang
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy , Xuzhou Medical University , Xuzhou 221004 , People's Republic of China . ; ; Tel: +86 516 83262137
| | - Xiaoke Gu
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy , Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy , Xuzhou Medical University , Xuzhou 221004 , People's Republic of China . ; ; Tel: +86 516 83262137
| |
Collapse
|
4
|
Gou Y, Li J, Fan B, Xu B, Zhou M, Yang F. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents. Eur J Med Chem 2017; 134:207-217. [DOI: 10.1016/j.ejmech.2017.04.026] [Citation(s) in RCA: 57] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2017] [Revised: 04/10/2017] [Accepted: 04/11/2017] [Indexed: 01/27/2023]
|
5
|
Li XY, Yu Y, Jia M, Jin MN, Qin N, Zhao C, Duan HQ. Terminamines K-S, Antimetastatic Pregnane Alkaloids from the Whole Herb of Pachysandra terminalis. Molecules 2016; 21:E1283. [PMID: 27681716 PMCID: PMC6273090 DOI: 10.3390/molecules21101283] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2016] [Revised: 09/12/2016] [Accepted: 09/13/2016] [Indexed: 11/16/2022] Open
Abstract
Nine new pregnane alkaloids (1-9), together with eight known alkaloids (10-17), were isolated from the whole herb of Pachysandra terminalis. Their structures were elucidated on the basis of spectroscopic analyses. In addition, the isolates were examined for their ability to inhibit the migration of MDA-MB-231 cells induced by the chemokine epidermal growth factor (EGF). Alkaloids 1, 5, 7, 9, 12, and 17 presented significant anti-metastasis activities compared with the positive reagent, LY294002.
Collapse
Affiliation(s)
- Xiang-Yu Li
- Tianjin Key Laboratory on Technologies Enabling Development Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
| | - Yang Yu
- Tianjin Key Laboratory on Technologies Enabling Development Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
| | - Miao Jia
- Tianjin Key Laboratory on Technologies Enabling Development Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
| | - Mei-Na Jin
- Tianjin Key Laboratory on Technologies Enabling Development Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
| | - Nan Qin
- Tianjin Key Laboratory on Technologies Enabling Development Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
| | - Chuan Zhao
- Tianjin Key Laboratory on Technologies Enabling Development Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
| | - Hong-Quan Duan
- Tianjin Key Laboratory on Technologies Enabling Development Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
| |
Collapse
|